Mirati Therapeutics (MRTX) PT Lowered to $75 at Barclays

May 25, 2023 3:28 AM EDT Send to a Friend
Barclays analyst Matthew Bouley lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login